Opendata, web and dolomites

POC products

A novel microfluid-based modular system to address POC challenges within the field of coagulation and hemostasis

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 POC products project word cloud

Explore the words cloud of the POC products project. It provides you a very rough idea of what is the project "POC products" about.

majority    solutions    coagulation    markets    independent    strategy    outside    modular    emergencies    exists    network    niches    oral    labs    reached    performing    opportunity    accelerate    solution    hematology    hospitals    clinical    entry    levels    hospital    ageing    core    competitors    therapies    health    microfluidic    corrected    plan    diversify    anticoagulation    monitored    segments    laboratories    proprietary    vital    improvements    flexibility    business    events    cardiology    hemostasis    commercialization    extend    poc    sales    anticoagulants    care    measured    worldwide    company    weight    lack    reactions    device    outcome    diagnostic    eliminates    direct    multistep    monitoring    distributors    hemorrhagic    lines    kols    barrier    molecular    possibility    run    population    prescribed    follow    feasibility    renal    centralized    industrialization    advertised    iline    patient    microsystems    ivd    building    noacs    tests    create    patented    size    biomarkers    platform    validation    lowering    market    heparin    customization    opens    15    complete    critical    cagr    monitor   

Project "POC products" data sheet

The following table provides information about the project.

Coordinator
ILINE MICROSYSTEMS S.L. 

Organization address
address: CL PASEO MIKELETEGI 69 1
city: DONOSTIA-SAN SEBASTIAN
postcode: 20009
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Spain [ES]
 Project website http://www.ilinemicrosystems.com/nw/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3.1.3. (Treating and managing disease)
 Code Call H2020-SMEINST-1-2015
 Funding Scheme SME-1
 Starting year 2015
 Duration (year-month-day) from 2015-07-01   to  2015-12-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    ILINE MICROSYSTEMS S.L. ES (DONOSTIA-SAN SEBASTIAN) coordinator 50˙000.00

Map

 Project objective

The New Oral Anticoagulants (NOACs) are widely advertised, with CAGR 15%/year, as they lack the necessity for monitoring of the patient. It is now corrected by increased levels of renal failure and hemorrhagic events. The project is focused on the validation and industrialization of new IVD POC device that will provide solutions to monitor low molecular weight heparin and NOACs which are not monitored by any existing POC systems. The proposed solution is improving patient care and management and lowering the increasing cost of centralized patient management related to the ageing of the population. This opens a business opportunity for our company since no POC device exists capable of performing similar diagnostic. Our solution has no direct competitors worldwide. The expected outcome is a complete diagnostic system based on proprietary microfluidic Core Technology patented by iLine Microsystems. This will extend the diagnostic range of the POC anticoagulation therapies that now can only be reached by multistep reactions run in centralized labs and accelerate the development of future tests. The feasibility study will focus on the business plan. Market size and niches can be measured for NOACs and their use in patient’s management. Both new lines of product are aiming at distinct market segments, emergencies, hospital tests or independent laboratories. Commercialization will follow the established strategy of sales via worldwide distributors. This approach eliminates the market entry barrier in hospitals and health care. We are building the clinical network including KOLs in the fields of hematology, cardiology and Critical Care where majority of the NOACs are prescribed and monitoring is vital. The proposed solution, due to its modular design and flexibility, has the unique potential for customization and improvements. The modular platform, create the possibility to diversify the markets and design products based on biomarkers outside of hemostasis and coagulation.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "POC PRODUCTS" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "POC PRODUCTS" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.3.)

LEGACy (2019)

CeLac and European consortium for a personalized medicine approach to Gastric Cancer

Read More  

PanCareFollowUp (2019)

PanCareFollowUp: Novel, patient-centred survivorship care to improve care quality, effectiveness, cost-effectiveness and accessibility for survivors and caregivers

Read More  

INTE-AFRICA (2019)

Integrating and decentralising diabetes and hypertension services in Africa

Read More